Barclays analyst issues OVERWEIGHT recommendation for RNSDF on April 9, 2024 04:32AM ET. RNSDF was trading at $49.86 at issue of the analyst recommendation.Historical Analyst RecommendationsLatest 10 recommendationsReport DateAnalyst CompanyActionPrevious...
UBS analyst issues NEUTRAL recommendation for TSLA on April 8, 2024 10:23AM ET. The previous analyst recommendation was Neutral.TSLA was trading at $172.2898 at issue of the analyst recommendation.The overall...
Morgan Stanley analyst issues OVERWEIGHT recommendation for F on April 5, 2024 11:26AM ET. The previous analyst recommendation was Overweight.F was trading at $13.255 at issue of the analyst recommendation.The...
Citigroup analyst issues BUY recommendation for GM on April 4, 2024 04:15AM ET. The previous analyst recommendation was Buy.GM was trading at $45.17 at issue of the analyst recommendation.The overall...
BMO Capital analyst issues OUTPERFORM recommendation for HOG on April 3, 2024 05:50AM ET. The previous analyst recommendation was Outperform.HOG was trading at $43.09 at issue of the analyst recommendation.The...
Oppenheimer analyst issues PERFORM recommendation for TSLA on April 2, 2024 09:45AM ET. The previous analyst recommendation was Perform.TSLA was trading at $164.775 at issue of the analyst recommendation.The overall...
Barclays analyst issues UNDERWEIGHT recommendation for NIO on April 2, 2024 06:07AM ET. The previous analyst recommendation was Overweight.NIO was trading at $4.64 at issue of the analyst recommendation.The overall...
UBS analyst issues NEUTRAL recommendation for POAHY on April 2, 2024 04:25AM ET. POAHY was trading at $5.23 at issue of the analyst recommendation.Historical Analyst RecommendationsLatest 10 recommendationsReport DateAnalyst CompanyActionPrevious...
Morgan Stanley analyst issues OVERWEIGHT recommendation for NIO on April 1, 2024 09:29AM ET. The previous analyst recommendation was Overweight.NIO was trading at $4.6452 at issue of the analyst recommendation.The...
Morgan Stanley analyst issues OVERWEIGHT recommendation for XPEV on April 1, 2024 09:28AM ET. The previous analyst recommendation was Overweight.XPEV was trading at $7.75 at issue of the analyst recommendation.The...
